PATRICIA CHACON: Open Payments
NPI 1043789308 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 66 payments from 17 companies in 2025. Trend: 2023 $356 · 2024 $454 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $232 |
| Lilly USA, LLC | 8 | $222 |
| AstraZeneca Pharmaceuticals LP | 12 | $203 |
| Amgen Inc. | 8 | $137 |
| Dexcom, Inc. | 4 | $86 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| Exact Sciences Corporation | 3 | $51 |
| SANOFI-AVENTIS U.S. LLC | 2 | $42 |
| PFIZER INC. | 2 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
Products named: MOUNJARO, Wegovy, FARXIGA, Ozempic, Dexcom G6 Transmitter, EVENITY, OTEZLA, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
